Tuesday, February 7, 2012

• Ladies, Who's Your Baseball Boyfriend --- PHILADELPHIA, Feb. 7, 2012
  Posted at 4:20 PM
  Girl gamer, Missy Wedig, creates a single draftee, fantasy baseball mini-game with delicious twist. Girls can pick one player to be their Baseball Boyfriend. During the baseball season, each player will earn points based on their boyfriends stats. The girl with the most points at the end of the season wins bragging rights for having the hottest boyfriend. (Photo: http://photos.prnewswire.com/prnh/20120207/CG49515) Football is over for the season and spring training is just a few weeks away. To many baseball fans this means ... read more
• Freelancers Worldwide Go Crazy Over Freelancer.com's 'Expose Our Logo' Contest --- SYDNEY, Feb. 7, 2012
  Posted at 4:04 PM
  Freelancer.com, the world's largest outsourcing and crowdsourcing marketplace, today announced the top 20 finalists in its US$25,000 'Expose Our Logo' contest. Over 440 video entries were received involving tens of thousands of freelancers from all points of the globe. "Our annual competitions harness the power of the crowd to create the most viral, musical, visible and public exposure of our logo, all while having a lot of fun!" said Matt Barrie, Chief Executive of Freelancer.com. "This year we were totally overwhelmed ... read more
• Material Sciences Corporation Announces New Web Site --- ELK GROVE VILLAGE, Ill., Feb. 7, 2012
  Posted at 3:23 PM
  Material Sciences Corporation, a leading provider of material-based solutions for acoustical and coated applications, today announced that the company is launching its new redesigned web site. The revamped web site offers quick and easy access to essential information regarding MSC's product lines and markets served, in a user friendly interface. (Photo: http://photos.prnewswire.com/prnh/20120207/DE49541 ) For more information, visit www.matsci.com. About Material Sciences Corporation Material Sciences Corporation is a leading provider of material-based solutions for acoustical and coated applications. The company uses its expertise in ... read more
• Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference --- THE WOODLANDS, Texas, Feb. 7, 2012
  Posted at 3:00 PM
  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the 2012 BIO CEO & Investor Conference in New York on Tuesday, February 14, 2012 at 10:00 a.m. Eastern Time. At the conference, which is hosted by the Biotechnology Industry Organization (BIO), Dr. Sands will provide an overview on Lexicon's clinical development programs and milestones. A live webcast of the presentation will be available through Lexicon's ... read more
• MEDICREA’s PASS MIS: FDA Approval and First Surgery in the US --- LYON, France
  Posted at 2:53 PM
  

  The MEDICREA group (Paris:ALMED) (FR0004178572-ALMED), listed on Alternext by NYSE Euronext Paris, a medical company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, today announced the approval by the FDA of the PASS MIS system and the first PASS MIS surgery performed ... read more
• MannKind to Present at Upcoming Conferences --- VALENCIA, Calif.
  Posted at 2:40 PM
  

  MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences. The 14th Annual BioCEO Investor Conference on February 14, ... read more
• National Federation of the Blind Testifies Before Senate Committee on Importance of Accessible Educational Technology --- WASHINGTON
  Posted at 2:27 PM
  Mark Riccobono, executive director of the National Federation of the Blind Jernigan Institute, testified today before a hearing of the Senate Health, Education, Labor and Pensions (HELP) Committee. The hearing, “The Promise of Accessible Technology: Challenges and Opportunities,” was convened to explore the barriers and opportunities ... read more
• Express Scripts Announces Fourth Quarter 2011 Earnings Conference Call --- ST. LOUIS, Feb. 7, 2012
  Posted at 2:16 PM
  Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, February 22, 2012 after the market closes and will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 23, 2012, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). This call is being webcast and can be accessed at Express Scripts Web site at www.express-scripts.com Express Scripts, Inc., one of the ... read more
• New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly(TM) Master Mix for Molecular and Synthetic Biology Applications --- IPSWICH, Mass. and LA JOLLA, Calif., Feb. 7, 2012
  Posted at 2:00 PM
  New England Biolabs, Inc. (NEB) and Synthetic Genomics, Inc. (SGI) jointly announce that they have entered into a licensing agreement whereby NEB will introduce a master mix based on Gibson Assembly(TM), a revolutionary technology developed by Dr. Daniel Gibson and his colleagues at the J. Craig Venter Institute (JCVI) as part of a program sponsored by SGI. The financial details of this agreement were not disclosed. (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b ) Gibson Assembly enables the rapid assembly of multiple DNA fragments using a one-step, ... read more
• Synthetic Genomics, Inc. Announces Agreement with New England Biolabs to Launch Gibson Assembly(TM) Master Mix Product for Synthetic and Molecular Biology Applications --- LA JOLLA, Calif. and IPSWICH, Mass., Feb. 7, 2012
  Posted at 2:00 PM
  Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and New England Biolabs, Inc. (NEB), today jointly announced that they have entered into a non-exclusive licensing agreement whereby NEB will commercialize the Gibson Assembly(TM) Master Mix. This product is based on the Gibson Assembly(TM) method which was developed by Daniel Gibson, Ph.D., and colleagues at the J. Craig Venter Institute (JCVI) as part of a program sponsored by ... read more
• Navidea Biopharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference --- DUBLIN, Ohio
  Posted at 1:52 PM
  

  Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) today announced that Dr. Mark Pykett, President and Chief Executive Officer, will participate at the 14th Annual BIO CEO & Investor Conference, hosted by the Biotechnology Industry Organization (BIO), on February 13-14 at the Waldorf Astoria in New York City. ... read more
• Light Reading's Test of Cisco's Cloud Services Network Infrastructure --- NEW YORK, Feb. 7, 2012
  Posted at 1:40 PM
  Light Reading (www.lightreading.com), the leading online publication for the global telecom industry, has published the second part of the world's first publicly available test of an end-to-end cloud services infrastructure, focusing on intelligent cloud network infrastructure. The report is available for free at http://www.lightreading.com/ciscoseries (Logo: http://photos.prnewswire.com/prnh/20110913/SF67580LOGO-a) The tests, conducted by the independent European Advanced Network Testing Center, covered Cisco's solutions for IPv6 migration as well as a method to optimize customer access to services based on automatic parameterization of the network. ... read more
• AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its Board --- LEXINGTON, Mass.
  Posted at 1:30 PM
  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Rajiv De Silva and Gino Santini to its board of directors, effective immediately. Mr. De Silva is currently president of Valeant Pharmaceuticals International, Inc. and chief operating officer of its Specialty Pharmaceuticals business. Mr. Santini retired in ... read more
• OrthoSensor Presents at the Canaccord Genuity Musculoskeletal Conference --- SUNRISE, FL
  Posted at 1:30 PM
  

  SUNRISE, FL -- (Marketwire) -- 02/07/12 -- OrthoSensor, Inc., the leader in intelligent orthopedics, announced that management presented at the Canaccord Genuity Musculoskeletal Conference taking place today in San Francisco. "OrthoSensor is leading the way in Intelligent Orthopedics, a new field that harnesses the latest innovations in sensors, microelectronics and wireless communications with the goal of improving healthcare outcomes and reducing the cost of treating musculoskeletal disease," said Jay Pierce, Chief Executive Officer of OrthoSensor. "We have launched our ... read more
• IAC Appoints Jeff Kip Executive Vice President and Chief Financial Officer --- NEW YORK, Feb. 7, 2012
  Posted at 1:25 PM
  IAC (Nasdaq: IACI) announced today that Jeff Kip will join IAC as Executive Vice President & Chief Financial Officer. Mr. Kip succeeds Thomas J. McInerney, whose intended departure after more than 12 years with the Company was announced last summer. "Jeff has great experience and a strategic mind. I'm excited about the contributions he's sure to make here at IAC in the coming years," said Greg Blatt, CEO, IAC. Mr. Kip joins IAC from Panera Bread (Nasdaq: PNRA) ... read more
• Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2011 Financial Results Conference Call on Monday, February 27, 2012 --- EAST BRUNSWICK, N.J., Feb. 7, 2012
  Posted at 1:15 PM
  Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company's fourth quarter and year-end 2011 financial results will be released prior to the open of the market on Monday, February 27, 2012. David Y. Norton, Interim Chief Executive Officer, Kenneth J. Zuerblis, Executive Vice President and Chief Financial Officer and Louis Ferrari, Executive Vice President, President North American Commercial Operations will host an investment community conference call beginning at 9:00 a.m. Eastern Time on February 27, 2012 to discuss these ... read more
• Cardiovascular Systems Reports Fiscal 2012 Second-Quarter Financial Results --- ST. PAUL, Minn.
  Posted at 1:05 PM
  

  Cardiovascular Systems, Inc. (Nasdaq: CSII): Revenues increased 5 percent over the second quarter of fiscal 2011, and 6 percent over the first quarter of fiscal 2012 to $19.7 million ... read more
• NuPathe to Present at Upcoming Investor Conferences --- CONSHOHOCKEN, PA
  Posted at 1:05 PM
  

  CONSHOHOCKEN, PA -- (Marketwire) -- 02/07/12 -- NuPathe Inc. (NASDAQ: PATH), an emerging biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced that Jane Hollingsworth, chief executive officer, will present company overviews at two upcoming investor conferences. On Tuesday, February 14, 2012, NuPathe will present at the 14th Annual BIO CEO & Investor Conference at 3:00 p.m. EST. The conference is being held at The Waldorf Astoria Hotel ... read more
• Pandora CFO to Present at the Goldman Sachs Technology & Internet Conference --- OAKLAND, Calif., Feb. 7, 2012
  Posted at 1:05 PM
  Pandora (NYSE: P), the leader in internet radio, today announced that the company's Chief Financial Officer will present at the Goldman Sachs Technology & Internet Conference on Tuesday, February 14, 2012 in San Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20110615/SF20192LOGO) Mr. Cakebread will present at the Goldman Sachs Technology & Internet Conference at 10:20AM (PST) / 1:20PM (EST). Live audio webcast of the presentation will be available on Pandora's Investor Relations website at http://investor.pandora.com. ABOUT PANDORA Pandora gives people music they love anytime, anywhere, through ... read more
• Codexis Reports Fourth Quarter and Full Year 2011 Results --- REDWOOD CITY, Calif., Feb. 7, 2012
  Posted at 1:05 PM
  Codexis, Inc. (NASDAQ: CDXS), a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced financial results for the fourth quarter and year ended December 31, 2011. "In 2011, we launched our CodeXyme(TM) cellulase enzymes and CodeXol(TM) detergent alcohol product lines," said Alan Shaw, Ph.D., President and CEO of Codexis, Inc. "In 2012 we are focused on delivering world-class CodeXyme(TM) cellulase enzymes to our development partners, piloting production of CodeXol(TM), and delivering continued sales ... read more